S&P 500   3,326.16 (+0.59%)
DOW   27,091.62 (+0.98%)
QQQ   270.75 (+0.14%)
MSFT   214.10 (+0.38%)
GOOGL   1,476.71 (+0.23%)
CGC   19.11 (-1.09%)
TSLA   1,474.52 (-0.84%)
MU   50.81 (-0.96%)
GE   6.15 (+0.16%)
T   30.05 (+0.13%)
F   6.88 (+0.29%)
DIS   127.83 (+8.99%)
BA   167.77 (+1.64%)
S&P 500   3,326.16 (+0.59%)
DOW   27,091.62 (+0.98%)
QQQ   270.75 (+0.14%)
MSFT   214.10 (+0.38%)
GOOGL   1,476.71 (+0.23%)
CGC   19.11 (-1.09%)
TSLA   1,474.52 (-0.84%)
MU   50.81 (-0.96%)
GE   6.15 (+0.16%)
T   30.05 (+0.13%)
F   6.88 (+0.29%)
DIS   127.83 (+8.99%)
BA   167.77 (+1.64%)
S&P 500   3,326.16 (+0.59%)
DOW   27,091.62 (+0.98%)
QQQ   270.75 (+0.14%)
MSFT   214.10 (+0.38%)
GOOGL   1,476.71 (+0.23%)
CGC   19.11 (-1.09%)
TSLA   1,474.52 (-0.84%)
MU   50.81 (-0.96%)
GE   6.15 (+0.16%)
T   30.05 (+0.13%)
F   6.88 (+0.29%)
DIS   127.83 (+8.99%)
BA   167.77 (+1.64%)
S&P 500   3,326.16 (+0.59%)
DOW   27,091.62 (+0.98%)
QQQ   270.75 (+0.14%)
MSFT   214.10 (+0.38%)
GOOGL   1,476.71 (+0.23%)
CGC   19.11 (-1.09%)
TSLA   1,474.52 (-0.84%)
MU   50.81 (-0.96%)
GE   6.15 (+0.16%)
T   30.05 (+0.13%)
F   6.88 (+0.29%)
DIS   127.83 (+8.99%)
BA   167.77 (+1.64%)
Log in

NASDAQ:XRAYDENTSPLY SIRONA Stock Price, Forecast & News

$46.79
+0.10 (+0.21 %)
(As of 08/5/2020 09:57 AM ET)
Add
Compare
Today's Range
$46.22
Now: $46.79▼
$47.36
50-Day Range
$41.27
MA: $43.72▼
$45.24
52-Week Range
$31.58
Now: $46.79▼
$60.87
Volume146,158 shs
Average Volume1.33 million shs
Market Capitalization$10.25 billion
P/E Ratio126.46
Dividend Yield0.90%
Beta1.03
DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist, and dental laboratories; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners and laboratories. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and urology products directly to patients, as well as through distributors to urologists, urology nurses, and general practitioners. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in York, Pennsylvania.
Read More
DENTSPLY SIRONA logo

Beat the Market (BTM) Rank™

Analyst Opinion: 2.3Community Rank: 2.4Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

2.01 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Dental equipment & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:XRAY
Previous Symbol
CUSIP24903010
CIK818479
Webwww.dentsplysirona.com
Phone844-546-3722

Debt

Debt-to-Equity Ratio0.33
Current Ratio2.02
Quick Ratio1.36

Price-To-Earnings

Trailing P/E Ratio126.46
Forward P/E Ratio33.42
P/E Growth4.01

Sales & Book Value

Annual Sales$4.03 billion
Price / Sales2.54
Cash Flow$4.12 per share
Price / Cash Flow11.35
Book Value$22.91 per share
Price / Book2.04

Profitability

EPS (Most Recent Fiscal Year)$2.45
Net Income$262.90 million
Net Margins2.12%
Return on Equity10.70%
Return on Assets6.38%

Miscellaneous

Employees15,200
Outstanding Shares219,080,000
Market Cap$10.25 billion
Next Earnings Date8/6/2020 (Confirmed)
OptionableOptionable
$46.79
+0.10 (+0.21 %)
(As of 08/5/2020 09:57 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive XRAY News and Ratings via Email

Sign-up to receive the latest news and ratings for XRAY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











DENTSPLY SIRONA (NASDAQ:XRAY) Frequently Asked Questions

How has DENTSPLY SIRONA's stock been impacted by COVID-19 (Coronavirus)?

DENTSPLY SIRONA's stock was trading at $42.56 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, XRAY shares have increased by 9.9% and is now trading at $46.79.
View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of DENTSPLY SIRONA?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last year. There are currently 7 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for DENTSPLY SIRONA.

When is DENTSPLY SIRONA's next earnings date?

DENTSPLY SIRONA is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020.
View our earnings forecast for DENTSPLY SIRONA.

How can I listen to DENTSPLY SIRONA's earnings call?

DENTSPLY SIRONA will be holding an earnings conference call on Thursday, August 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were DENTSPLY SIRONA's earnings last quarter?

DENTSPLY SIRONA Inc (NASDAQ:XRAY) announced its quarterly earnings results on Friday, May, 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.41 by $0.02. The medical instruments supplier had revenue of $873.30 million for the quarter, compared to analyst estimates of $873 million. DENTSPLY SIRONA had a net margin of 2.12% and a return on equity of 10.70%. The business's revenue for the quarter was down 7.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.49 EPS.
View DENTSPLY SIRONA's earnings history.

How often does DENTSPLY SIRONA pay dividends? What is the dividend yield for DENTSPLY SIRONA?

DENTSPLY SIRONA declared a quarterly dividend on Wednesday, July 29th. Stockholders of record on Friday, September 25th will be given a dividend of $0.10 per share on Friday, October 9th. This represents a $0.40 annualized dividend and a dividend yield of 0.85%. The ex-dividend date of this dividend is Thursday, September 24th.
View DENTSPLY SIRONA's dividend history.

What price target have analysts set for XRAY?

14 brokerages have issued 12-month target prices for DENTSPLY SIRONA's stock. Their forecasts range from $38.00 to $66.00. On average, they expect DENTSPLY SIRONA's stock price to reach $49.64 in the next twelve months. This suggests a possible upside of 6.1% from the stock's current price.
View analysts' price targets for DENTSPLY SIRONA.

What are Wall Street analysts saying about DENTSPLY SIRONA stock?

Here are some recent quotes from research analysts about DENTSPLY SIRONA stock:
  • 1. According to Zacks Investment Research, "DENTSPLY’s healthcare business witnessed solid growth in the last reported quarter driven by strong demand for Wellspect medical supplies. Also, Digital Dentistry witnessed a strong first quarter, attributable to strong sales of new products — Primescan and Primemill. However, Per the first-quarter 2020 preliminary announcement, DENTSPLY witnessed deterioration in both earnings and revenues. Core Technology & Equipment and Consumables units witnessed year-over-year decline in the last reported quarter. Contraction in margins is a concern. Meanwhile, revenues at the Consumables segment were sluggish in the quarter. Sales in Europe also declined. Unfavorable foreign currency and restructuring costs are expected to impact the company in 2020. DENTSPLY has underperformed the industry in a year's time." (7/23/2020)
  • 2. Barrington Research analysts commented, "We are now modeling $2.35, up from our prior $2.32 estimate." (8/5/2019)

Has DENTSPLY SIRONA been receiving favorable news coverage?

Media stories about XRAY stock have been trending somewhat negative this week, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. DENTSPLY SIRONA earned a coverage optimism score of -1.0 on InfoTrie's scale. They also assigned media coverage about the medical instruments supplier a news buzz of 5.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the stock's share price in the near term.
View the latest news about DENTSPLY SIRONA.

Are investors shorting DENTSPLY SIRONA?

DENTSPLY SIRONA saw a decrease in short interest in the month of June. As of June 30th, there was short interest totaling 5,010,000 shares, a decrease of 14.7% from the June 15th total of 5,870,000 shares. Based on an average daily trading volume, of 2,630,000 shares, the days-to-cover ratio is currently 1.9 days. Currently, 2.3% of the shares of the stock are sold short.
View DENTSPLY SIRONA's Current Options Chain.

Who are some of DENTSPLY SIRONA's key competitors?

Some companies that are related to DENTSPLY SIRONA include Align Technology (ALGN), West Pharmaceutical Services (WST), Cooper Companies (COO), Quidel (QDEL), Neogen (NEOG), Haemonetics (HAE), ICU Medical (ICUI), STAAR Surgical (STAA), Merit Medical Systems (MMSI), Cerus (CERS), OraSure Technologies (OSUR), Atrion (ATRI), Meridian Bioscience (VIVO), Anika Therapeutics (ANIK) and Antares Pharma (ATRS).
View all competitors.

What other stocks do shareholders of DENTSPLY SIRONA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DENTSPLY SIRONA investors own include NVIDIA (NVDA), Intel (INTC), QUALCOMM (QCOM), Gilead Sciences (GILD), IBM (IBM), Boeing (BA), General Electric (GE), Netflix (NFLX), Vertex Pharmaceuticals (VRTX) and Comcast (CMCSA).

Who are DENTSPLY SIRONA's key executives?

DENTSPLY SIRONA's management team includes the following people:
  • Mr. Nicholas William Alexos, Exec. VP & CFO (Age 55)
  • Mr. Keith John Ebling, EVP, Gen. Counsel & Sec. (Age 50)
  • Ms. Maureen J. MacInnis, Sr. VP, Chief HR Officer & Communications (Age 58)
  • Mr. Donald M. Casey Jr., CEO & Director (Age 59)
  • Mr. Dominique P. Legros, Sr. VP of Equipment, Technologies & Healthcare Segment (Age 59)

What is DENTSPLY SIRONA's stock symbol?

DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."

Who are DENTSPLY SIRONA's major shareholders?

DENTSPLY SIRONA's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (0.70%), Robeco Institutional Asset Management B.V. (0.38%), Manitou Investment Management Ltd. (0.30%), Boston Trust Walden Corp (0.27%), Raymond James & Associates (0.25%) and Hardman Johnston Global Advisors LLC (0.24%). Company insiders that own DENTSPLY SIRONA stock include Betsy D Holden, Daniel P Key, Donald M Jr Casey, Eric Brandt, Gregory T Lucier, Markus Boehringer, Maureen J Macinnis, Michael C Alfano, Michael J Coleman and William E Newell.
View institutional ownership trends for DENTSPLY SIRONA.

Which institutional investors are selling DENTSPLY SIRONA stock?

XRAY stock was sold by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Candriam Luxembourg S.C.A., Robeco Institutional Asset Management B.V., Douglas Lane & Associates LLC, Mackay Shields LLC, Arizona State Retirement System, First Trust Advisors LP, and DNB Asset Management AS. Company insiders that have sold DENTSPLY SIRONA company stock in the last year include Michael C Alfano, and William E Newell.
View insider buying and selling activity for DENTSPLY SIRONA.

Which institutional investors are buying DENTSPLY SIRONA stock?

XRAY stock was purchased by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Reinhart Partners Inc., UBS Group AG, Boston Trust Walden Corp, Raymond James & Associates, PGGM Investments, Janney Montgomery Scott LLC, and Envestnet Asset Management Inc.. Company insiders that have bought DENTSPLY SIRONA stock in the last two years include Betsy D Holden, Daniel P Key, Donald M Jr Casey, and Gregory T Lucier.
View insider buying and selling activity for DENTSPLY SIRONA.

How do I buy shares of DENTSPLY SIRONA?

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is DENTSPLY SIRONA's stock price today?

One share of XRAY stock can currently be purchased for approximately $46.79.

How big of a company is DENTSPLY SIRONA?

DENTSPLY SIRONA has a market capitalization of $10.25 billion and generates $4.03 billion in revenue each year. The medical instruments supplier earns $262.90 million in net income (profit) each year or $2.45 on an earnings per share basis. DENTSPLY SIRONA employs 15,200 workers across the globe.

What is DENTSPLY SIRONA's official website?

The official website for DENTSPLY SIRONA is www.dentsplysirona.com.

How can I contact DENTSPLY SIRONA?

DENTSPLY SIRONA's mailing address is 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The medical instruments supplier can be reached via phone at 844-546-3722 or via email at [email protected]

This page was last updated on 8/5/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.